Laureate Announces Second Manufacturing Agreement with Cytheris
PRINCETON, New Jersey and PARIS, March 27 /PRNewswire/ --
- Laureate to Manufacture Cytheris' Lead Product Candidate, INTERLEUKIN-7, currently in clinical trials for treatment of HIV, HCV and cancer
Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, announced today that it has entered into a cGMP contract manufacturing agreement with Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation. According to the agreement, Laureate will manufacture Cytheris' lead product…